There are 2867 resources available
613P - Clinical characteristics and treatment outcomes of women with recurrent uterine leiomyosarcoma
Presenter: Hua Yuan
Session: Poster session 09
614P - Tolerance and preliminary efficacy of intraperitoneal (IP) nivolumab after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients (pts) with advanced ovarian carcinoma: A phase I study with expansion cohort (ICONIC)
Presenter: Pauline Corbaux
Session: Poster session 09
615TiP - NIRVANA-1: A multicentre randomized study comparing carboplatin-paclitaxel (CP) followed by niraparib (nira) to CP–bevacizumab (bev) followed by nira-bev in patients with FIGO stage III ovarian high-grade epithelial cancer and no residual disease after upfront surgery
Presenter: Gilles Freyer
Session: Poster session 09
629P - Ultra-sensitive monitoring of leukemia patients using superRCA mutation detection assays
Presenter: Lei Chen
Session: Poster session 09
630P - Comparison of different bone marrow detection methods in the diagnosis and prognosis of bone marrow involvement in diffuse large b cell lymphoma
Presenter: Kaiqi Zhao
Session: Poster session 09
631P - A meta-analysis of the outcome of post-transplant lymphoproliferative disorder in adult patients after hematopoietic stem cell transplant
Presenter: Leela Kantamneni
Session: Poster session 09
632P - Prognostic relevance of pre-treatment c-reactive protein to albumin ratio in patients with diffuse large b cell lymphoma
Presenter: Tania-Mihaela Nicolaescu
Session: Poster session 09
633P - Determining the prognostic value of end of treatment (EOT) 18F-choline positron emission tomography (PET) in patients treated with primary central nervous system lymphoma (PCNSL) who respond to first-line therapy: A single centre retrospective study at the Royal Marsden Hospital (RMH)
Presenter: Su Li
Session: Poster session 09